MetaCap

Bio-Techne Earnings

NASDAQ: TECHHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

72.67-0.03 (-0.04%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Bio-Techne earnings summary

In its most recent report on Nov 11, 2026 (Sep/2026), TECH posted EPS of $0.36 versus the $0.40 consensus estimate, a negative surprise of 10.0%. Bio-Techne beat the consensus EPS estimate in 0 of the last 3 quarters, with a median surprise of -10.0%. Quarterly EPS is up 12.5% from the same quarter a year earlier.

Across the last 16 reports, TECH shares moved an average of 4.4% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.

Summary generated from market data by MetaCap's automated system. Methodology

TECH earnings history

Bio-Techne reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 11, 2026$0.40$0.36-10.0%-0.2%
Nov 6, 2026$0.40$0.37-7.5%+0.0%
Nov 4, 2026$0.40$0.36-10.0%+0.0%
Aug 24, 2026—$0.36—+0.1%
May 6, 2026—$0.32—-10.5%
Feb 4, 2026—$0.24—-10.3%
Nov 5, 2025—$0.24—+3.4%
Aug 22, 2025—$-0.11—-4.3%
May 8, 2025—$0.14—-1.6%
Feb 6, 2025—$0.22—-9.4%
Nov 5, 2024—$0.21—-11.0%
Aug 22, 2024—$0.26—+2.4%
May 6, 2024—$0.31—+3.6%
Feb 7, 2024—$0.17—+5.4%
Nov 7, 2023—$0.31—+6.2%
Aug 23, 2023—$0.47—-1.7%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related